Skip to main content
Top
Published in: BMC Pediatrics 1/2022

Open Access 01-12-2022 | Magnetic Resonance Imaging | Research

Assessment of the prevalence and associated risk factors of pediatric hydrocephalus in diagnostic centers in Addis Ababa, Ethiopia

Authors: Blein Mulugeta, Girma Seyoum, Abebe Mekonnen, Elbet Ketema

Published in: BMC Pediatrics | Issue 1/2022

Login to get access

Abstract

Background

Hydrocephalus (HCP) is a common disorder of cerebral spinal fluid (CSF) physiology resulting in abnormal expansion of the cerebral ventricles. Infants commonly present with progressive macrocephaly whereas children older than 2 years generally present with signs and symptoms of intracranial hypertension. Neither qualitatively nor quantitatively are there adequate data to determine the prevalence and incidence of HCP in the developing world. HCP is a treatable condition that when left untreated, has fatal consequences.

Objective

The objective of this study was to assess the prevalence of pediatric HCP and associated risk factors in diagnostic centers in Addis Ababa, Ethiopia.

Methods

This study was conducted using a cross-sectional facility-based study design over a two-time period, i.e. a 2-year retrospective data collection from January 2018 to January 2020 included 1101 patients and a prospective data collection from May 2019 to February 2020 included 99 patients. Children aged 5 years and below who came to the selected diagnostic centers for MRI/CT examination were studied. The collected data were analyzed using binary logistic regression.

Result

The retrospective study included 639(58%) males and 462 (42%) females. The mean age calculated was 22.3 months. Infants aged younger than 24 months 753 (68.4%) were significantly associated with HCP development (P < 0.05). In the retrospective study, HCP etiologies; Aqueductal stenosis (17.9%), Neural Tube defects (NTDs) (35.7%), post-infectious (10.1%) were identified. In the prospective study, the gender and age distribution was 57(57.6%) males, 42 (42.4%) females, 60.6% infants aged younger than 24 months with a mean age of 24.9 months. Inadequate consumption of folic acid and development of HCP was found to be statistically significant (P < 0.05). In the prospective study, HCP etiologies; Aqueductal stenosis (26.1%), Neural Tube defects (26.08%), and post-infectious (8.69%) were identified. The 3 years prevalence of HCP calculated in both studies was 22% (223 per 1000 live births).

Conclusion

The results of this study suggest that the high prevalence of HCP was due to the high prevalence of aqueductal stenosis and neural tube defects; with a small contribution of post-infectious causes. The majority of infants who present with HCP were aged younger than 24 months.
Literature
1.
go back to reference Oi S, Takahashi S, Macías IS, Oi S, Miyajima M, Qureshi M, Inagaki T, Rpmero MA, Ma J, Ohira T. Journal of Hydrocephalus. 2009. Oi S, Takahashi S, Macías IS, Oi S, Miyajima M, Qureshi M, Inagaki T, Rpmero MA, Ma J, Ohira T. Journal of Hydrocephalus. 2009.
2.
go back to reference Kahle KT, Kulkarni AV, Limbrick DD Jr, Warf BC. Hydrocephalus in children. Lancet. 2016;387(10020):788–99.CrossRef Kahle KT, Kulkarni AV, Limbrick DD Jr, Warf BC. Hydrocephalus in children. Lancet. 2016;387(10020):788–99.CrossRef
3.
go back to reference Chi J. Time trends and demographics of deaths from congenital hydrocephalus in children in the US: National Center for Health Statistics data, 1979 to 1998. J Neurosurg. 2005;103(2):111. Chi J. Time trends and demographics of deaths from congenital hydrocephalus in children in the US: National Center for Health Statistics data, 1979 to 1998. J Neurosurg. 2005;103(2):111.
4.
go back to reference Warf BC, Collaboration EANR. Pediatric hydrocephalus in East Africa: prevalence, causes, treatments, and strategies for the future. World Neurosurg. 2010;73(4):296–300.CrossRef Warf BC, Collaboration EANR. Pediatric hydrocephalus in East Africa: prevalence, causes, treatments, and strategies for the future. World Neurosurg. 2010;73(4):296–300.CrossRef
5.
go back to reference Barthélemy EJ, Valtis YK, Cochran MF, Martineau L, Park K, Mendel JB, et al. Patterns of Hydrocephalus in Rural Haiti: A Computed Tomography–Based Study. World Neurosurg. 2018;119:257–61.CrossRef Barthélemy EJ, Valtis YK, Cochran MF, Martineau L, Park K, Mendel JB, et al. Patterns of Hydrocephalus in Rural Haiti: A Computed Tomography–Based Study. World Neurosurg. 2018;119:257–61.CrossRef
6.
go back to reference Laeke T, Tirsit A, Biluts H, Murali D, Wester K. Pediatric hydrocephalus in Ethiopia: treatment failures and infections: a hospital-based, retrospective study. World Neurosurg. 2017;100:30–7.CrossRef Laeke T, Tirsit A, Biluts H, Murali D, Wester K. Pediatric hydrocephalus in Ethiopia: treatment failures and infections: a hospital-based, retrospective study. World Neurosurg. 2017;100:30–7.CrossRef
7.
go back to reference Kinasha A, Kahamba J, Semali I. Complications of ventriculoperitoneal shunts in children in Dar Es Salaam. East Central Afr J Surg. 2005;10(2):55–9. Kinasha A, Kahamba J, Semali I. Complications of ventriculoperitoneal shunts in children in Dar Es Salaam. East Central Afr J Surg. 2005;10(2):55–9.
8.
go back to reference Komolafe EO, Adeolu AA, Komolafe MA. Treatment of cerebrospinal fluid shunting complications in a Nigerian neurosurgery programme. Pediatr Neurosurg. 2008;44(1):36–42.CrossRef Komolafe EO, Adeolu AA, Komolafe MA. Treatment of cerebrospinal fluid shunting complications in a Nigerian neurosurgery programme. Pediatr Neurosurg. 2008;44(1):36–42.CrossRef
9.
go back to reference Lane JD, Mugamba J, Ssenyonga P, Warf BC. Effectiveness of the Bactiseal universal shunt for reducing shunt infection in a sub-Saharan African context: a retrospective cohort study in 160 Ugandan children. J Neurosurg Pediatr. 2014;13(2):140–4.CrossRef Lane JD, Mugamba J, Ssenyonga P, Warf BC. Effectiveness of the Bactiseal universal shunt for reducing shunt infection in a sub-Saharan African context: a retrospective cohort study in 160 Ugandan children. J Neurosurg Pediatr. 2014;13(2):140–4.CrossRef
12.
go back to reference Garne E, Loane M, Addor MC, Boyd PA, Barisic I, Dolk H. Congenital hydrocephalus—prevalence, prenatal diagnosis and outcome of pregnancy in four European regions. Eur J Paediatr Neurol. 2010;14:150–5.CrossRef Garne E, Loane M, Addor MC, Boyd PA, Barisic I, Dolk H. Congenital hydrocephalus—prevalence, prenatal diagnosis and outcome of pregnancy in four European regions. Eur J Paediatr Neurol. 2010;14:150–5.CrossRef
13.
go back to reference Munch TN, Rostgaard K, Rasmussen M-LH, Wohlfahrt J, Juhler M, Melbye M. Familial aggregation of congenital hydrocephalus in a nationwide cohort. Brain. 2012;135(8):2409–15.CrossRef Munch TN, Rostgaard K, Rasmussen M-LH, Wohlfahrt J, Juhler M, Melbye M. Familial aggregation of congenital hydrocephalus in a nationwide cohort. Brain. 2012;135(8):2409–15.CrossRef
14.
go back to reference Jeng S, Gupta N, Wrensch M, Zhao S, Wu YW. Prevalence of congenital hydrocephalus in California, 1991-2000. Pediatr Neurol. 2011;45(2):67–71.CrossRef Jeng S, Gupta N, Wrensch M, Zhao S, Wu YW. Prevalence of congenital hydrocephalus in California, 1991-2000. Pediatr Neurol. 2011;45(2):67–71.CrossRef
15.
go back to reference Liu J, Jin L, Li Z, Zhang Y, Zhang L, Wang L, et al. Prevalence and trend of isolated and complicated congenital hydrocephalus and preventive effect of folic acid in northern China, 2005–2015. Metab Brain Dis. 2018;33(3):837–42.CrossRef Liu J, Jin L, Li Z, Zhang Y, Zhang L, Wang L, et al. Prevalence and trend of isolated and complicated congenital hydrocephalus and preventive effect of folic acid in northern China, 2005–2015. Metab Brain Dis. 2018;33(3):837–42.CrossRef
16.
go back to reference Eke CB, Uche EO, Chinawa JM, Obi IE, Obu HA, Ibekwe RC. Epidemiology of congenital anomalies of the central nervous system in children in Enugu, Nigeria: a retrospective study. Ann Afr Med. 2016;15(3):126.CrossRef Eke CB, Uche EO, Chinawa JM, Obi IE, Obu HA, Ibekwe RC. Epidemiology of congenital anomalies of the central nervous system in children in Enugu, Nigeria: a retrospective study. Ann Afr Med. 2016;15(3):126.CrossRef
17.
go back to reference Santos MM, Rubagumya DK, Dominic I, Brighton A, Colombe S, O’Donnell P, et al. Infant hydrocephalus in sub-Saharan Africa: the reality on the Tanzanian side of the lake. J Neurosurg Pediatr. 2017;20(5):423–31.CrossRef Santos MM, Rubagumya DK, Dominic I, Brighton A, Colombe S, O’Donnell P, et al. Infant hydrocephalus in sub-Saharan Africa: the reality on the Tanzanian side of the lake. J Neurosurg Pediatr. 2017;20(5):423–31.CrossRef
18.
go back to reference Gathura E, Poenaru D, Bransford R, Albright AL. Outcomes of ventriculoperitoneal shunt insertion in sub-Saharan Africa. J Neurosurg Pediatr. 2010;6(4):329–35.CrossRef Gathura E, Poenaru D, Bransford R, Albright AL. Outcomes of ventriculoperitoneal shunt insertion in sub-Saharan Africa. J Neurosurg Pediatr. 2010;6(4):329–35.CrossRef
19.
go back to reference Adeloye A. Management of infantile hydrocephalus in Central Africa. Trop Dr. 2001;31(2):67–70. Adeloye A. Management of infantile hydrocephalus in Central Africa. Trop Dr. 2001;31(2):67–70.
20.
go back to reference Awad ME. Infantile hydrocephalus in the south-western region of Saudi Arabia. Ann Trop Paediatr. 1992;12(3):335–8.CrossRef Awad ME. Infantile hydrocephalus in the south-western region of Saudi Arabia. Ann Trop Paediatr. 1992;12(3):335–8.CrossRef
21.
go back to reference Reefhuis J, Honein MA. Maternal age and non-chromosomal birth defects, Atlanta—1968–2000: teenager or thirty-something, who is at risk? Birth Defects Res A Clin Mol Teratol. 2004;70(9):572–9.CrossRef Reefhuis J, Honein MA. Maternal age and non-chromosomal birth defects, Atlanta—1968–2000: teenager or thirty-something, who is at risk? Birth Defects Res A Clin Mol Teratol. 2004;70(9):572–9.CrossRef
22.
go back to reference Van Landingham M, Nguyen TV, Roberts A, Parent AD, Zhang J. Risk factors of congenital hydrocephalus: a 10 year retrospective study. J Neurol Neurosurg Psychiatry. 2009;80(2):213–7.CrossRef Van Landingham M, Nguyen TV, Roberts A, Parent AD, Zhang J. Risk factors of congenital hydrocephalus: a 10 year retrospective study. J Neurol Neurosurg Psychiatry. 2009;80(2):213–7.CrossRef
23.
go back to reference Wald N, Law M, Morris J, Wald D. Quantifying the effect of folic acid. Lancet. 2001;358(9298):2069–73.CrossRef Wald N, Law M, Morris J, Wald D. Quantifying the effect of folic acid. Lancet. 2001;358(9298):2069–73.CrossRef
24.
go back to reference Munch T, Rasmussen M, Wohlfahrt J, Juhler M, Melbye M. Risk factors for primary congenital hydrocephalus-a nationwide cohort study. Am J Epidemiol. 2012;175:S57. Oxford Univ Press Inc Journals Dept, 2001 Evans Rd, Cary, NC 27513 USA. Munch T, Rasmussen M, Wohlfahrt J, Juhler M, Melbye M. Risk factors for primary congenital hydrocephalus-a nationwide cohort study. Am J Epidemiol. 2012;175:S57. Oxford Univ Press Inc Journals Dept, 2001 Evans Rd, Cary, NC 27513 USA.
Metadata
Title
Assessment of the prevalence and associated risk factors of pediatric hydrocephalus in diagnostic centers in Addis Ababa, Ethiopia
Authors
Blein Mulugeta
Girma Seyoum
Abebe Mekonnen
Elbet Ketema
Publication date
01-12-2022
Publisher
BioMed Central
Published in
BMC Pediatrics / Issue 1/2022
Electronic ISSN: 1471-2431
DOI
https://doi.org/10.1186/s12887-022-03212-6

Other articles of this Issue 1/2022

BMC Pediatrics 1/2022 Go to the issue